Immix Biopharma
IMMX
IMMX
25 hedge funds and large institutions have $6.1M invested in Immix Biopharma in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
30% less capital invested
Capital invested by funds: $8.77M → $6.1M (-$2.67M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Holders
25
Holding in Top 10
–
Calls
$13K
Puts
$2K
Top Buyers
| 1 | +$149K | |
| 2 | +$125K | |
| 3 | +$38.5K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$11.9K |
| 5 |
TAM
Tocqueville Asset Management
New York
|
+$8.2K |
Top Sellers
| 1 | -$422K | |
| 2 | -$306K | |
| 3 | -$64K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$46K |
| 5 |
Squarepoint
New York
|
-$45.6K |